Business Model: B2B
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
CNF Investments, LLC (CNF) is a private investment firm with a focus on venture capital and private equity opportunities. CNF manages over $350 million in capital, with current investments in technology, healthcare, and energy, and will consider direct as well as fund investments. CNF is an active investor that looks to partner with experienced and passionate entrepreneurs and co-investors to build great companies. CNF focuses on growth stage companies, but will consider investments in early and late stage businesses as well. CNF conducts thorough and efficient diligence processes but focuses most of its analysis on the potential investment&s;s management team and other key players. CNF believes that success is based on the right combination of people, experience, hard work, focus, and execution. CNF is an affiliate of Clark Enterprises, Inc.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2008 | Aquestive Therapeutics | Debt Financing | 0 |
5/2010 | Flyby Media | Series A | 3.5M |
4/2015 | Ingo Money | Venture Round | 6.7M |
7/2015 | CircleBack | Series C | 0 |
11/2014 | Echo360 | Series C | 18M |
7/2013 | ReelGenie | Seed Round | 850k |
1/2013 | SnagFilms | Venture Round | 6M |
4/2014 | SurfWatch | Series A | 3.5M |
12/2006 | Digital Bridge Communications Corp. | Series A | 11M |
10/2018 | Svelte Medical Systems | Venture Round | 22M |
1/2006 | Vital Sensors | Venture Round | 0 |
1/2016 | Blitsy | Series B | 0 |
1/2014 | Kareo | Series F | 29.5M |
5/2008 | Innovative Biosensors | Venture Round | 9.5M |
1/2008 | Digital Bridge Communications Corp. | Series B | 0 |
9/2007 | Aldagen | Series C | 9M |
3/2014 | Speek | Series A | 0 |
5/2007 | TerraGo Technologies | Series A | 0 |
8/2013 | Speek | Seed Round | 0 |
4/2009 | TerraGo Technologies | Venture Round | 0 |
1/2013 | Speek | Seed Round | 1.2M |
3/2013 | TerraGo Technologies | Unattributed | 5.5M |
4/2000 | PaylinX | Series B | 0 |
8/2016 | Ceros | Series B | 0 |
2/2019 | Ceros | Series C | 0 |
9/2014 | AnyPresence | Series B | 6M |
4/2014 | Closely | Series A | 3M |
12/2004 | Prestwick Pharmaceuticals | Series B | 37M |
9/2006 | Overture Technologies | Series B | 3.7M |
11/2015 | Upskill | Venture Round | 13M |
12/2008 | Overture Technologies | Series C | 6M |
10/2006 | Prestwick Pharmaceuticals | Series C | 60M |
6/2011 | Revance Therapeutics | Series D | 45M |
2/2016 | Svelte Medical Systems | Private Equity Round | 44.4M |
3/2014 | Svelte Medical Systems | Equity | 5M |
10/2005 | Verax Biomedical | Series B | 15M |
4/2014 | Quad Learning | Series B | 0 |
7/2015 | Kareo | Series G | 55.4M |
1/2013 | ViewLift | Venture Round | 6M |
12/2007 | Verax Biomedical | Series E | 2.5M |
10/2013 | Viridis Learning | Seed Round | - |
11/2009 | Svelte Medical Systems | Debt Financing | 0 |
6/2008 | Orchestr8 | Series C | 2M |
2/2015 | Vascular Therapies | Private Equity Round | 16.2M |
12/2007 | Orchestr8 | Series C | 3M |
12/2014 | Orchestro | Venture Round | 0 |
2/2019 | Ceros | Series C | 0 |
10/2018 | Svelte Medical Systems | Venture Round | 0 |
8/2016 | Ceros | Series B | 0 |
2/2016 | Svelte Medical Systems | Private Equity Round | 0 |
1/2016 | Blitsy | Series B | 0 |
11/2015 | Upskill | Venture Round | 0 |
7/2015 | Kareo | Series G | 0 |
7/2015 | CircleBack | Series C | 0 |
4/2015 | Ingo Money | Venture Round | 0 |
2/2015 | Vascular Therapies | Private Equity Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|